🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

10,225 results for “He” Clear

  1. methoxy polyethylene glycol-epoetin beta [Mircera]

    Hoffmann-La Roche

    Anemia

    approved small molecule terminated

    2 trials

  2. minimally invasive cholecystolithotomy with gallbladder reservation

    The First People's Hospital of Lianyungang

    Gallstones

    approved other active

    1 trial

  3. morphine

    United Therapeutics Europe Ltd

    Cardiovascular Disease

    approved small molecule completed

    1 trial

  4. mouse nerve growth factor

    The First People's Hospital of Lianyungang

    Cerebral Small Vessel Diseases

    approved small molecule active

    1 trial

  5. mycophenolate mofetil

    United Therapeutics Europe Ltd

    IGA Nephropathy

    approved small molecule completed

    1 trial

  6. mycophenolate mofetil (Myfenax)

    Teva Pharma GmbH

    Stable Renal Transplant Recipients

    approved small molecule terminated

    1 trial

  7. neoadjuvant therapy

    The First People's Hospital of Lianyungang

    Hepatocellular Carcinoma Resectable

    approved other active

    1 trial

  8. oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  9. pegylated interferon alpha and plus ribavirin

    Hospital Authority, Hong Kong

    Chronic Hepatitis C

    approved small molecule completed

    1 trial

  10. physiotherapeutic treatment

    Universal Integrated

    Morquio's Disease

    approved other terminated

    1 trial

  11. prescribing anapproved drug, examination

    The First People's Hospital of Lianyungang

    Irritable Bowel Syndrome With Diarrhea

    approved small molecule active

    1 trial

  12. profound neuromuscular blockade

    The First People's Hospital of Lianyungang

    Profound Muscle Relaxation

    approved small molecule active

    1 trial

  13. quetiapine fumarate tablet (Seroquel)

    The First People's Hospital of Lianyungang

    Bipolar Disorder

    approved small molecule active

    1 trial

  14. rFVIIIFc

    Sanofi Pasteur

    Hemophilia A With Inhibitors

    approved mab completed

    1 trial

  15. ramelteon

    Takeda

    Migraine Headache

    approved small molecule terminated

    1 trial

  16. recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Healthy

    approved small molecule completed

    1 trial

  17. recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  18. rhGM-CSF group

    The First People's Hospital of Lianyungang

    Mycoses

    approved small molecule completed

    1 trial

  19. rhTPO

    The First People's Hospital of Lianyungang

    Primary Immune Thrombocytopenia

    approved small molecule active

    1 trial

  20. rhTPO

    The First People's Hospital of Lianyungang

    Thrombocytopenia

    approved small molecule active

    1 trial

  21. rituximab combined with corticosteroids

    The First People's Hospital of Lianyungang

    Primary Membranous Nephropathy

    approved small molecule active

    1 trial

  22. ropivacaine

    The First People's Hospital of Lianyungang

    Injury of Upper Limb

    approved small molecule completed

    1 trial

  23. sIPV+DTaP+HepA

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Vaccination

    approved mab active

    1 trial

  24. saproterin dihydrochloride

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources